Joseph Truitt's Net Worth
$1.14 Million
Who is Joseph Truitt?
Joseph Truitt has an estimated net worth of $1.14 Million. This is based on reported shares across multiple companies, which include Larimar Therapeutics, Inc., BIOSPECIFICS TECHNOLOGIES CORP, and ACHILLION PHARMACEUTICALS INC.
SEC CIK
Joseph Truitt's CIK is 0001452429
Past Insider Trading and Trends
2014 was Joseph Truitt's most active year for acquiring shares with 6 total transactions. Joseph Truitt's most active month to acquire stocks was the month of April. 2020 was Joseph Truitt's most active year for disposing of shares, totalling 11 transactions. Joseph Truitt's most active month to dispose stocks was the month of December. 2019 saw Joseph Truitt paying a total of $419,785.40 for 1,230,484 shares, this is the most they've acquired in one year. In 2020 Joseph Truitt cashed out on 2,996,266 shares for a total of $2,500,050.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Larimar Therapeutics, Inc. (LRMR) Snapshot price: $8.05
InvestorJoseph Truitt owns 2,750 units of Common Stock which is worth $22,137.50. From 2020 to 2024 Joseph Truitt acquired a total of 2,750 shares in Larimar Therapeutics, Inc. at a cost of $10,257.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
∞
| 2.75K |
$3.73 | $10,257.50 | 2.75K |
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOSPECIFICS TECHNOLOGIES CORP No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACHILLION PHARMACEUTICALS INC No price found
Chief Executive OfficerJoseph Truitt used to own units in Common Stock but no longer holds any shares there. From 2009 to 2020 Joseph Truitt acquired a total of 236,984 shares in ACHILLION PHARMACEUTICALS INC at a cost of $515,995.40, Joseph also disposed a total of 236,984 shares of ACHILLION PHARMACEUTICALS INC equalling to $1,640,205.65.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.50K |
$6.30 | -$22,050.00 |
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
$4.76 | -$431,161.75 | 3.5K |
Oct 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
∞
| 3.5K |
$4.06 | $14,210.00 | 3.5K |
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
|
—
|
0
|
$5.82 | -$250,000.00 |
0
|
Aug 25
| |||
Form 4
|
—
|
0
|
$4.32 | -$175,000.00 |
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
$3.42 | -$260,208.50 |
0
|
Jun 9 - Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||